ARTICLE | Company News
Pierre Fabre, Maruho deal
January 21, 2013 8:00 AM UTC
Pierre Fabre granted Maruho exclusive, Japanese rights to develop and commercialize propranolol to treat infantile hemangioma. Maruho will be responsible for regulatory approval in Japan. Pierre Fabre...